Loading...
  • Neural Cell Adh
  • Anti-CD56 recognizes two proteins of the neural cell adhesion molecule, the basic molecule expressed on most neuroectodermally derived tissues and neoplasms (e.g. retinoblastoma, medulloblastomas, astrocytomas, neuroblastomas, and small cell carcinomas). (novusbio.com)
  • Anti-CD56
  • Staining profiles of o.n. cultured lymphocytes, obtained as indicated in the Materials and Methods section, by using PE-labeled antiCD40L TRAP-1, FITC-labeled anti-CD3, or anti-CD56 mAbs in a classical double fluorescence assay. (nih.gov)
  • We also assessed the expression of CD40L on polyclonal NK effectors derived from peripheral blood of normal donors, by double staining with anti-CD40L mAb TRAP-1 and anti-CD3 or anti-CD56 mAb. (nih.gov)
  • Anti-CD56 antibody IHC of human brain, cortex. (mybiosource.com)
  • Anti-CD56 plays an important role in the diagnosis of nodal and nasal NK/T-cell lymphomas. (novusbio.com)
  • CD16
  • The CD16+CD56- NK cell subgroup had a higher proliferative capacity, whereas the CD16±CD56+ NK cell subgroup was mainly cytotoxic, and unaffected by HIV serostatus. (ingentaconnect.com)
  • Design
  • CD antigen cancer therapeutics have diverse design and target due to which they could be used for several malignancies. (marketreport.jp)
  • Products
  • CD antigen cancer market is expected to witness introduction of several products which will help the pharmaceutical companies to generate significant revenues. (marketreport.jp)
  • shows
  • Commercial success of marketed CD antigen cancer therapeutics shows that they would be generating significant revenues in coming years. (marketreport.jp)
  • attractive
  • CD56 CAR therapy therefore represents an attractive immunotherapy option and its use in patients with relapsed refractory myeloma should be considered. (aacrjournals.org)